Immune Checkpoints

Format
Reactivity Species
Host Species
Category
Reported Applications
10 per page
Sort by

Toggle Details

Showing 1 – 10 of 149 results Showing all 149 results Showing the single result No results found
Name
Applications ?
Prod No.
Clone
Pkg. Size / Quantity
Alt Names:
DEFA5; DEF5; HD-5
Reactivity:
Human
Immunogen:
Recombinant Human HD5 (aa 20-94).
Dot
,
ELISA
,
IHC FFPE
,
WB
D405
8C8
Max:
Min: 1
Step: 1
Alt Names:
B7-1
Reactivity:
Human
Immunogen:
Purified Recombinant Human B7-1 (>98%) (Accession # P33681)
CyTOF®
,
ELISA Cap
,
FC
,
IHC FFPE
,
N
B566
37711
Max:
Min: 1
Step: 1
Alt Names:
4-1BB, TNFRSF9, CD137 Antigen, T-Cell Antigen ILA
Reactivity:
Human
Immunogen:
NS0-Derived Recombinant Human 4-1BB Extracellular Domain (Accession # Q07011)
CyTOF®
,
FC
,
WB
B591
145501
Max:
Min: 1
Step: 1
Alt Names:
TNFSF9, 4-1BB Ligand, 4-1BBL
Reactivity:
Human
Immunogen:
Purified Recombinant Human 4-1BB Ligand (>98%) (Accession # P41273.1)
CyTOF®
,
FC
,
WB
L251
282220
Max:
Min: 1
Step: 1
Alt Names:
IL-2Rα, CD25, Ly-43, p55, Tac
Reactivity:
Human
Immunogen:
Recombinant human peripheral blood mononuclear cells (PBMCs)
ELISA
,
FC
,
IF Staining
,
IP
,
WB
C9305
7G7B6
Max:
Min: 1
Step: 1
Alt Names:
B7-DC, CD273, PDL2, B7DC, Clone 3.2
Reactivity:
Mouse/Human
Immunogen:
Made in PD-L2 knockout mouse fusion partner X63-Ag8.653 myeloma cells
B
,
FC
,
WB
P679
3.2.B8
Max:
Min: 1
Step: 1
Alt Names:
B7-DC, CD273, PDL2, B7DC, Clone 3.2
Reactivity:
Mouse/Human
Immunogen:
Made in PD-L2 knockout mouse fusion partner X63-Ag8.653 myeloma cells
B
,
FC
P379
3.2.B8
Max:
Min: 1
Step: 1
Alt Names:
MGC138290, Tp44
Reactivity:
Human
Immunogen:
Purified Recombinant Human CD28 (>98%) (Accession # P10747)
FA
,
WB
C1400
37407
Max:
Min: 1
Step: 1
Alt Names:
MGC138290, Tp44
Reactivity:
Human
CODEX®
,
IHC FF
C511
CD28.2
Max:
Min: 1
Step: 1
Alt Names:
MGC138290, Tp44
Reactivity:
Human
CODEX®
,
Costim
,
FC
,
IHC FF
,
IP
C2820
CD28.2
Max:
Min: 1
Step: 1
1 2 15
Cookie Policy
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy.